Episode Transcript
Transcripts are displayed as originally observed. Some content, including advertisements may have changed.
Use Ctrl + F to search
0:12
Hello everyone and welcome to Access for
0:17
Care to Alzheimer's Disease, an event that we are hosting
0:19
with the Alzheimer's Association.
0:22
I am Steven Collens, the CEO of MATTER.
0:25
We are a healthcare technology
0:25
incubator and innovation hub.
0:29
Built on a belief that collaboration
0:29
between entrepreneurs and industry leaders
0:34
is the best way to develop
0:34
healthcare solutions.
0:37
Our mission is to accelerate the
0:37
pace of change of healthcare,
0:40
and we do three things in service of this
0:40
mission. First, we incubate startups.
0:45
We launched in 2015, and since then we've worked with more
0:47
than 850 companies that range from very
0:52
early to growth stage startups, and we
0:52
have a suite of services to help them.
0:56
At every stage of development, our member companies have raised more
0:58
than $5 billion to fuel their growth.
1:03
Second, we work with large organizations like
1:04
health systems and life sciences companies
1:07
and payers to help them strengthen
1:07
their innovation capacity. We help them
1:12
find value in emerging
1:12
technology solutions,
1:15
unlock the full potential of
1:15
their internal innovators,
1:19
and create a more human-centered
1:19
healthcare experience through system level
1:23
collaborations. And third matter is a nexus for those
1:24
who are passionate about healthcare
1:28
innovation. We bring people together to be inspired
1:29
and learn and connect with each other.
1:33
And we put together forums like
1:33
the one we're here for today.
1:38
This is our second year working with
1:38
the Alzheimer's Association to advance
1:42
innovation to improve the lives of
1:42
those living with Alzheimer's disease or
1:47
related dementias. Last year,
1:49
the pitch competition focused on early
1:49
detection in primary care settings.
1:53
And this year the focus is on solutions
1:53
that increase access to quality
1:58
person-centered care for people living
1:58
with Alzheimer's disease in underserved
2:03
communities, inequities in access to care for
2:04
people with Alzheimer's disease,
2:08
STEM from socioeconomic disparities,
2:12
limiting resources and healthcare
2:12
options for those in those communities.
2:16
These disparities manifest
2:16
in delayed diagnosis,
2:20
inadequate support services, and a lack of tailored interventions
2:22
perpetuating a cycle of unequal treatment
2:26
and outcomes for individuals
2:26
affected by Alzheimer's.
2:31
Today we've brought together leaders
2:31
who are working in this space to discuss
2:34
these barriers, to care
2:34
how to improve access,
2:37
how our healthcare system can and
2:37
should collaborate and opportunities for
2:42
innovation. Dr. Jay Bott leads the Deloitte
2:43
Center for Health Solutions and the
2:48
Deloitte Health Equity Institute, and he is a practicing
2:51
internist and geriatrician.
2:56
Ashley Alexander is CEO of the
2:56
Kelsey Research Foundation.
3:00
Ashley also co-chairs the Alzheimer's
3:00
Association Innovation Roundtable.
3:06
Katie Evans is the Chief Mission
3:06
Engagement Officer of the Alzheimer's
3:10
Association, and our moderator
3:10
today is Laura McIntyre,
3:15
senior Director of Health Systems
3:15
at the Alzheimer's Association.
3:18
She works with health systems and health
3:18
plans to increase early detection and
3:23
enhance quality of care for those at
3:23
risk of Alzheimer's disease and related
3:28
dementias. If you have questions
3:28
for any of the panelists,
3:32
please drop them into the chat and Laura
3:32
will weave them into the conversation
3:36
as we go. And following
3:36
the panel discussion,
3:41
my colleague Casey Sheridan will
3:41
provide a brief overview of the second
3:45
annual Alzheimer's
3:45
Association pitch competition.
3:50
Thank you all for joining us today. I'm
3:50
looking forward to the conversation.
3:53
And with that, Laura, I will turn
3:53
it over to you to get started.
3:58
Thank you, Steven. So I'm so grateful to be here
4:00
today and talk about really
4:05
how we can improve access to
4:05
care and to introduce you to this
4:10
amazing panelist. So we'll
4:10
start with Dr. Bhatt.
4:14
Tell us a little bit about your role
4:14
and how you're currently working with
4:17
people living with Alzheimer's
4:17
disease and related dementias.
4:22
Thank you, Laura, and just real gratitude to the Alzheimer's
4:22
Association of your leadership and
4:27
for collaborating with matter.
4:29
I've just been fortunate to work with
4:29
matter over the years and tremendous value
4:34
that creates for the innovation ecosystem.
4:34
So I'm a primary care physician,
4:39
internist, geriatrician at a community health
4:39
center on the south side of Chicago.
4:42
So I directly care for those
4:42
with dementia or cognitive
4:46
impairment and delirium and with work with
4:51
their caregivers. So that experience is humbling
4:53
and it's just an honor to care for
4:58
patients with their
4:58
families and caregivers.
5:02
I also lead our Deloitte
5:02
Health Equity Institute,
5:05
which advances health equity as an
5:05
outcome. We do that through research,
5:09
through social impact with
5:09
community investments,
5:12
as well as building the capacity and
5:12
capabilities of people in our firm and
5:16
giving them experiences to engage
5:16
in purpose-based client and social
5:21
impact work as it
5:21
relates to health equity.
5:24
And so this issue has come
5:24
up through new care models,
5:29
thinking about biopharma and the
5:29
treatments and the drug discovery
5:33
process. Think about how do we
5:34
advance both treatment and
5:39
support for those that may be on their
5:39
way to dementia or have dementia.
5:44
And then our Center for Health Solutions
5:44
at Deloitte does research across the
5:48
industry in life sciences and
5:48
healthcare. And so I also personally,
5:54
my father has got mild cognitive
5:54
impairment on his way to
5:58
potentially dementia at a various continuum.
6:01
And so family experience as well.
6:08
Thank you. Thank you. Dr. Bhatt. Ashley,
6:11
tell us about your role and how
6:11
you're working with Alzheimer's.
6:14
Absolutely. I'm Ashley Alexander, president and CEO of Kelsey Research
6:16
Foundation in Houston, Texas.
6:21
We are the research affiliate of a large
6:21
multi-specialty physician group here in
6:25
Houston and oversee and implement all
6:25
research for their patient population and
6:30
for their physicians. And we've had the honor and privilege
6:32
of partnering with the local chapter in
6:36
the National Alzheimer's Association on
6:36
a variety of research projects over the
6:40
years. Most recently for Focus on Brain
6:41
Health with the US Pointer study,
6:45
we serve as part of the Houston
6:45
team implementing the US Pointer
6:50
study for our 455
6:50
participants here in Houston.
6:55
We also, in the future, are hoping to be part of some real
6:57
world clinical trials on the use of the
7:01
therapeutics that have been developed. And in a similar standpoint
7:03
on a personal front,
7:07
both my husband and I have lost our
7:07
maternal grandmothers to Alzheimer's and
7:12
dementia. And so there is a personal drive to
7:12
be involved and see advances in these
7:17
areas. Thank you. Thank you. Ashley and Katie.
7:21
Hi everyone. Katie Evans. I am the Chief Mission Engagement
7:23
Officer of the Alzheimer's Association.
7:27
And really just to ground everyone on
7:27
who the Alzheimer's Association is,
7:31
we're leading the way to end
7:31
Alzheimer's and all other dementia,
7:35
and that's by accelerating
7:35
global research,
7:37
driving risk reduction in early detection, and of course maximizing that
7:39
quality of care and support.
7:43
So in my current role, I have the
7:43
honor and privilege of leading a team,
7:48
and we're developing new products and
7:48
solutions for healthcare systems for
7:53
the long-term and community-based
7:53
organizations, the scientific community,
7:57
and then as well as people who are
7:57
of course living with Alzheimer's and
8:00
dementia and their care partners. So we're really trying to provide
8:02
that support and those resources for
8:07
these audiences so that we can both
8:07
accelerate research but then transform
8:11
clinical and care practice. And similar theme to the other panelists,
8:16
I actually lost my father
8:16
this summer to Alzheimer's,
8:19
so I'm in it in the fight
8:19
and ready to see what we can
8:24
do more together. Well, as you can see,
8:27
we have an amazing panel today
8:27
to talk about barriers to care
8:32
and then potential solutions. I
8:32
echo everything we've heard today.
8:37
I too have a father living with vascular
8:37
dementia entering the middle stage.
8:42
So not only do I live the work every day,
8:46
I live it when I leave this job to
8:46
care and provide the best care for
8:50
him. And so thinking about Alzheimer's,
8:53
we know that the number of the Americans
8:53
living with Alzheimer's today is
8:58
growing rapidly. More than 6 million Americans of
9:00
all ages have Alzheimer's and is the
9:05
size of the US population age
9:05
65 and older continues to grow.
9:09
So will the number and proportions of
9:09
Americans living with Alzheimer's and
9:13
other dementia. It's projected by 2050 that the
9:15
number of people living with
9:20
them, assuming that we don't have breakthroughs
9:20
to prevent or cure this disease will
9:25
likely be around 12.7 million.
9:29
And so as we think about that care and
9:29
how we will care for our older adults,
9:34
thinking about innovation, thinking about their current barriers
9:36
and how to overcome them are really
9:39
critical. And so Ashley,
9:42
what are the main barriers that come
9:42
to mind today that individuals who are
9:46
living with Alzheimer's are facing
9:46
when accessing quality care and support
9:51
services? So a couple of things that I hear about
9:53
from our participants in the US Pointer
9:58
study, many of which have
9:58
served as caregivers,
10:02
it is access and availability to care
10:02
teams and the coordination of those
10:07
care teams. A lot of challenges,
10:11
and we all know this
10:11
and are aware of it, but
10:17
the need for more neurologists
10:17
within our care continuum,
10:21
but also access to get
10:21
into primary care as well.
10:25
And then the coordination often for
10:25
these individuals of primary care in one
10:30
system and then subspecialists,
10:30
neurologists, et cetera,
10:33
and other systems and making
10:33
sure that you are having a
10:37
reconciliation of that medication of
10:37
the conditions that are happening.
10:41
And I also think to go expand
10:41
into the support services,
10:46
it's understanding what support services
10:46
exist within your community and then
10:50
gaining access to those support services.
10:50
You don't know what you don't know,
10:55
and you get into this and face a lot
10:55
of challenges and become overwhelmed.
10:59
And what can caregivers do and provide
10:59
and what can the individuals provide
11:03
or ask for and advocate for as well?
11:06
Yes, I agree. Ashley, Jay, what about you?
11:10
We know you're a practicing physician.
11:12
What barriers are you seeing for the
11:12
patients and the caregivers in accessing
11:16
quality care and support? So thank you so much Laura. And
11:24
just building on Ashley's comments,
11:28
which I think are spot on, one of the things I wanted to say is
11:29
that this is not just a moral imperative,
11:33
it's an economic imperative as well. And we see more frequent
11:35
hospital admissions, higher
11:39
more days in nursing home facilities,
11:42
nearly 55,000 yearly total cost
11:42
per person and poor quality of
11:47
life for both personal dementia and
11:47
they're typically unpaid caregivers.
11:50
So one is lack of information, education caregivers may be
11:52
unaware of available resources,
11:56
support groups and educational materials, but it's also the literacy levels
11:58
that various people may be at.
12:02
I typically take care of historically
12:02
underserved and historically marginalized
12:07
vulnerable and literacy
12:07
levels are quite variable.
12:11
So with a limited amount of time,
12:14
it requires a team that
12:14
coordinates around this
12:18
limited access to specialized cares. Kelsey had suggests. I think this can
12:20
lead to delays in diagnosis and inadequate
12:25
treatment. And then the others
12:25
fragmented healthcare system,
12:28
lacking coordination between
12:28
different clinicians,
12:32
team making it difficult for caregivers
12:32
to navigate through various services,
12:36
coordinate the care of their loved ones,
12:36
emotional and psychological stress,
12:41
feelings of isolation,
12:41
anxiety, depression.
12:44
And so the caregivers may need mental
12:44
health support, counseling, respite care,
12:48
and other peer support groups. The
12:48
financial burden as alluded to,
12:53
can be a challenge. And then lack of
12:53
this respite care and support services.
12:58
So caregivers that may need time off from
12:58
their responsibilities or need to work
13:03
something out with their
13:03
occupational responsibilities.
13:07
But by addressing these barriers,
13:09
I think caregivers can receive the
13:09
support they need to provide the best
13:12
possible care for their
13:12
loved ones with Alzheimer's.
13:15
Yes, I completely agree. And I
13:15
think about workforce as well.
13:20
And so even if we make those caregivers
13:25
aware, then we need a
13:25
well-trained workforce.
13:27
And so I think that's
13:27
an additional barrier.
13:29
So thinking about workforce and in
13:29
thinking about the healthcare ecosystem,
13:34
Katie, what are your thoughts around how
13:34
is the healthcare ecosystem currently
13:39
addressing these barriers? That's a good question, Laura.
13:41
I would say that better.
13:45
Alzheimer's disease care really
13:45
requires conversations about memory
13:50
at the earliest point of concerned and
13:50
having a knowledgeable and accessible
13:55
care team to diagnose,
13:55
monitor disease progression,
13:59
and then of course treat when appropriate. And we do know what effective
14:02
dementia care looks like. In fact,
14:06
there are some models of care
14:06
that have even been developed.
14:10
They've demonstrated both effectiveness
14:10
and proven out some cost savings.
14:14
So right now, we're
14:14
fortunate Laura and her team,
14:19
they're actually working with health
14:19
systems across the country to help each
14:23
system build their own
14:23
dementia care program.
14:26
But I'd also say that more needs to
14:26
be done to address these barriers,
14:30
especially for the rural
14:30
and underserved communities.
14:34
So for us to encourage and implement
14:34
more coordinated care models across
14:39
the country for people living with
14:39
Alzheimer's and other dementia.
14:42
We did launch this summer a dementia
14:42
care navigation round table.
14:48
And this round table is
14:48
supporting very broadly
14:52
implementation of
14:52
dementia care navigation,
14:55
and it's an effort to convene
14:55
experts where they can share best
15:00
practices, build and
15:00
disseminate resources.
15:04
The experts are really from across
15:04
the entire healthcare ecosystems.
15:09
So that includes systems,
15:09
clinicians, payers, researchers,
15:13
and just other stakeholders who are
15:13
really committed to advancing the delivery
15:17
of high quality person-centered
15:17
dementia care navigation.
15:21
And that's something else to note is
15:21
an important cornerstone for this work,
15:25
really centered on guiding principles
15:25
for dementia care navigation,
15:28
which were developed by a
15:28
group of dementia care experts
15:33
and convened by the
15:33
Alzheimer's Association.
15:35
And these guidelines were
15:35
recently published in the journal,
15:39
Alzheimer's and Dementia,
15:39
the Translational Research
15:44
Thank you, Katie. And that's really
15:44
a great update on where we are,
15:48
but we have a ways to
15:48
go. So I'm curious, Jay,
15:51
because of your role with Deloitte
15:51
and you think about the healthcare
15:55
ecosystem, how do you think
15:55
they are addressing barriers?
15:59
What is your perspective on that? Knowing the answer may be sometimes
16:01
they're not. And so I'm just curious,
16:05
what are your thoughts about how the
16:05
healthcare ecosystem is addressing them?
16:10
Yeah, I think the ecosystem
16:10
and the various players,
16:14
then I recognize this as a critical
16:14
issue and it's being addressed
16:18
in variable ways by
16:18
different stakeholders.
16:22
But the reality is that all
16:22
stakeholders need to come together.
16:25
And we're seeing some of
16:25
this play out with the guide
16:30
model, which is a new
16:30
model launched by CMS.
16:33
We've also seen this through collaborative
16:33
evidence-based collaborative care
16:37
models, Dr. Mel Bai and others
16:38
have driven this forward.
16:42
You have a scalable dementia care
16:42
coordination team that then has access,
16:47
coordinate delivery and monitoring
16:47
with the family caregiver,
16:50
patient counseling, self-management. You have memory care mental
16:52
health practitioners,
16:55
you have community resources
16:55
and primary care providers,
16:57
but that model also needs
16:57
supportive reimbursement.
17:01
Often we think about the
17:01
payment model and then, okay,
17:04
how do we box the care
17:04
into the payment model?
17:08
But it's really about what
17:08
is the care that people with
17:12
dementia and their caregivers need
17:17
with dignity and respect, and then how do we pay for that
17:18
effectively and where the various
17:23
approaches are going to be. So I
17:23
think there's certainly technology and
17:27
innovation that can help support
17:27
this using those solutions
17:32
as enablers to augment the work of care
17:32
teams that can improve the condition and
17:36
integration of care services for
17:36
individuals. Alzheimer's disease,
17:40
whether it's telemedicine,
17:40
voice activation,
17:43
predicting needs that may be necessary.
17:48
We're seeing this some with
17:48
around drug discovery as well as
17:53
artificial intelligence. But I
17:53
think that addressing health equity,
17:58
supporting innovation and addressing
17:58
affordability is really the pillars of the
18:02
CMS Innovation Center strategy
18:02
that the guide model supports.
18:06
And I suspect that more will
18:06
come on board, but we've seen
18:12
U-C-S-F-U-C-L-A and a number
18:12
of other academic centers
18:17
take these collaborative dementia care
18:17
models and move them into clinical
18:21
programs. And so we need
18:21
more of that happening.
18:24
We know there's evidence
18:24
about model today that works,
18:27
and we should test how we can
18:27
enhance those models that create
18:33
AAD a support for the dyad, those suffering from the DS and the
18:34
disease and those caring for 'em.
18:38
And I'm excited to see what emerges.
18:41
And we too are very
18:41
excited about guide and
18:46
implementing the models.
18:46
So thinking about that,
18:49
thinking about even the
18:49
potential solutions,
18:52
you had talked earlier Dr.
18:52
B about those underserved
18:56
populations. So what are
18:56
some unique barriers?
18:59
We know that African-Americans
18:59
and Hispanics are
19:04
disproportionately
19:04
affected by this disease.
19:06
And so what are some unique barriers? We're going to talk a little
19:09
about solutions in a little bit,
19:12
but what are some unique barriers that
19:12
we have to consider when we're developing
19:16
out innovations and solutions? So what's the barriers for
19:18
underserved populations?
19:22
I think one, as we think about
19:22
building on just the care model,
19:25
it's one in which the workforce
19:25
and the caregivers can
19:30
operate reliably and effectively.
19:30
And often if I see a patient,
19:35
it's 15 to 30 minutes the followup's,
19:35
15 new patient's, 30 minutes,
19:40
imagine how we are to get what
19:40
we need done in that time.
19:43
So you've got to think about what is the
19:43
continuum, what do you focus on there?
19:47
How do you have other players
19:47
on the team play a role?
19:50
How does technology enable
19:50
some of the support?
19:53
So I think you've got to think through
19:53
that model for your population.
19:57
One of the things is digital literacy. So we kind of think about what's
19:59
our own genius bar for patients that
20:04
need support with various
20:04
tools and the support for
20:09
caregivers. I think the other piece around treatment,
20:13
clinical trial diversity,
20:17
we know that we got to
20:17
continue to advance that,
20:21
although black Americans are twice as
20:21
likely as white Americans have Alzheimer's
20:24
and Hispanics, but 1.5 times likely we see
20:25
the clinical trial participants
20:31
don't reflect that.
20:31
I think in some of the more recent ones,
20:35
we've seen the Hispanic
20:35
community be represented better,
20:38
but still tough for the black community. And to the point made earlier
20:40
about rural communities,
20:42
I think that's a really
20:42
important issue as well.
20:45
And so as think about care models
20:45
got to account for the rural
20:50
needs as well. So I think when I think
20:50
about equity and inequities space,
20:55
it's racial and ethnic, certainly
20:55
disproportionately impacted,
20:58
but it's place-based
20:58
too. And it's veterans.
21:01
It's people that have had experiences
21:01
that may put them at higher
21:06
risk for dementia, and then it's the
21:06
social support and the caregivers,
21:10
which is a barrier. Some of them may not have the ability
21:11
to have caregiver support and if it's
21:15
unpaid even harder. So I think these are ones that
21:17
we've got to have the model and
21:22
stakeholders solve for. Yeah, absolutely. So Ashley,
21:27
when you mentioned clinical
21:27
trials and even participating,
21:30
I wondered to the US Pointer study, which really focused on
21:32
underserved communities,
21:35
what were some of the barriers that
21:35
really stood out to you all as you were
21:38
trying to not only recruit them
21:38
but then offer some of those
21:43
solutions? Absolutely. So we were lucky here in Houston for
21:45
the US pointer study and the US pointer
21:49
study overall to achieve over,
21:52
for the study overall 30%
21:52
participants of color in Houston,
21:55
we achieved 45% participants
21:55
of color for the US pointer,
21:58
which is focused on a lifestyle
21:58
intervention to reduce those at high risk.
22:04
But you enroll them in the study, how do you ensure that they still
22:06
participate and still make it to required
22:11
appointments and meetings and
22:11
transportation was a big issue for us,
22:15
and especially living in a
22:15
community that is a car based or
22:20
with limited great strong
22:20
public transportation.
22:23
So we were creative with
22:23
Ubers or with helping.
22:29
We often took meetings or
22:29
took appointments out to
22:33
home. And this was one benefit of
22:33
having our affiliation with our
22:38
medical group is their clinics are in
22:38
the communities so we could see patients
22:43
at the clinics that were closest to them
22:43
to reduce that transportation barrier.
22:49
These were little pieces
22:49
that we put in place,
22:51
but I agree the rural health is
22:51
something that I hope that we
22:56
can be innovative on. That was my
22:56
grandmother in a very rural setting.
23:00
And how do you get the care to her and
23:00
how do you get the diagnosis to her or
23:05
the ability to diagnose to her as well?
23:08
There's conversations we had at a meeting
23:08
yesterday of care at home or assessing
23:13
and testing people at home
23:13
where they are more comfortable,
23:18
but also where you have an opportunity
23:18
to assess their social determinants of
23:21
health that may be playing a role
23:21
in both their current care and
23:26
future care. And that kind of brings me to kind of
23:29
the other barrier that we think about.
23:32
And so Katie, what barriers come to mind?
23:35
And she mentioned social
23:35
determinants of health,
23:38
but what are other barriers that come
23:38
to mind among these diverse communities?
23:42
So when you think about these.
23:44
Older adults, they of course have some nuanced
23:45
healthcare needs that are really often
23:49
compounded by complex social issues.
23:51
And so if diagnosis occurs later,
23:55
it is typically what I just said
23:55
in the later stages of the disease.
23:59
And these individuals are more
23:59
cognitively and physically impaired
24:04
and therefore in need of more
24:04
medical care. So as a result,
24:08
the populations really are at a
24:08
greater risk, poor health outcomes,
24:13
they may receive inadequate care
24:13
or encounter barriers to care,
24:18
and they also face some staggering
24:18
treatment and care expenses.
24:23
So I know we're not
24:23
talking about solutions,
24:27
but I'm excited to get to that part. Yeah, absolutely. And it's actually
24:29
a great time to pivot to that.
24:33
And so we've identified and we've thought
24:33
about the barriers, transportation,
24:38
location, finances, language,
24:38
culturally competent,
24:43
all those things. But let's think about and pivot
24:44
to opportunities to improve
24:49
access. So Ashley, with a
24:49
complex healthcare system,
24:54
what have you seen actually
24:54
improves access to care.
24:59
With the system we're affiliated with, I've seen the leveraging
25:00
technology for virtual care,
25:05
both video visits and
25:05
also just virtual eVisits
25:10
or email-based visits
25:10
that you can conduct,
25:13
but that allows individuals
25:13
to have access to their
25:17
subspecialists and their primary care
25:17
in a more convenient timeframe in their
25:22
setting that is comfortable to them
25:22
and allow them to reduce some of those
25:27
transportation barriers. Now
25:27
you reduce transportation,
25:30
but you also increase technology,
25:30
potential technology barriers.
25:34
So what are we going to do there
25:34
and how do you address that?
25:36
And that is something that I think
25:36
is an ongoing question for all of us
25:40
today. So those are the pieces.
25:43
And then also taking care to the home. The facility we're affiliated with has
25:47
a care team that goes into the home of
25:51
individuals that those that are high risk
25:51
to help reduce those readmissions and
25:55
to ensure some of the coordination occurs
25:55
in particular after a discharge from a
26:00
hospital. Certainly.
26:02
And that's a great way to think
26:02
about going to the patient,
26:07
meeting them where they are. So we know that collaboration
26:10
in healthcare is key. In fact,
26:14
Dr. Bott has made reference
26:14
to that several times, right?
26:17
That the system is fragmented, but
26:17
there's opportunity for collaboration.
26:22
So Dr. Bott, what strategies can be implemented to
26:22
improve the coordination and integration
26:26
of care? You alluded to guide earlier.
26:29
And so thinking about navigating
26:29
multiple care systems,
26:33
you mentioned guide earlier, but what does that look like
26:35
in a solution for this care?
26:39
How do we improve that? And what are other thoughts about getting
26:41
this type of solution integrated into
26:46
the healthcare ecosystem? I would say that we have
26:48
evidence-based models,
26:52
the collaborative care model
26:52
that's been in play, that work.
26:57
The question is whether
26:57
there's will and desire to
27:03
implement those and scale 'em. Some of them may require
27:05
additional resources or investment,
27:08
but you could take the existing
27:08
approach of where you are
27:14
in a care setting and think
27:14
about what are the needs
27:19
that individual may have and
27:19
organize the workflows around that.
27:22
So there are alerts and various tools to help
27:25
early identification. And so I had
27:33
a few years ago, a high school
27:33
math teacher and I said,
27:39
tell me about how work is. Is it you feel like you're
27:41
operating at the same pace,
27:44
you're doing things appropriately, or
27:44
is it taking you longer or is it not?
27:48
And you can do a mini
27:48
mental status or the exam,
27:51
but asking people about what's happening
27:51
in their life elicits like, oh no,
27:55
actually it's slower. I need help for using spreadsheets
27:57
that once I really knew how to use.
28:03
So that signals, okay, I got to get this person
28:05
into an evaluation process
28:09
help you in that. So I think that one is figuring out
28:10
helping people work at the top of their
28:15
training. And medical assistants can play a role
28:15
as they do in our situation where we have
28:19
limited time and capacity. Our
28:19
care coordinators play a role.
28:22
If you have Medicaid managed care, the
28:22
care coordination can be supported there.
28:27
If it's with duals and Medicare,
28:30
there are other supports as well. And then I would say one of the recent
28:32
studies we launched was around employers
28:36
and that employers could catalyze
28:36
initial 20 years of health span.
28:40
So that's healthier life and longer
28:40
life for everyone and disproportionately
28:44
more for Alaska natives,
28:46
American Indians and the black community.
28:46
And part of it was using the
28:51
prevention methods, the science and
28:51
the approaches we already have today.
28:56
So there's a difference between
28:56
lifespan, which is longer life,
28:58
but maybe poor quality
28:58
of life and health span,
29:01
which is longer and healthier life.
29:03
And so we've got to address some of the
29:03
drivers of health that Ashley and Katie
29:07
have alluded to as part of that model.
29:12
And I also think that we're seeing
29:12
some technology approaches how to AI to
29:16
predict how the condition will affect
29:16
the brain physically over time or predict
29:20
how symptoms will change over time. So then that allows you to plan more
29:21
effectively for the future or genetic
29:26
profiles and create models of predict
29:26
who might more likely to develop later in
29:29
life this condition so that along with
29:29
sensors and technology to understand how
29:34
a person's behavior is
29:34
shifting or changing.
29:36
Are they doing something that's more
29:36
risky or signs that the health is
29:40
deteriorating? Absolutely. Thank you. Ashley.
29:45
How can healthcare professionals be
29:45
better equipped and trained to provide
29:48
culturally competent and person-centered
29:48
care for individuals living with
29:53
Alzheimer's disease? I personally believe that this
29:55
is something that in Houston
30:00
with the local chapter of
30:00
the Alzheimer's Association,
30:03
our organization has done well.
30:06
And I think it is partnering with
30:06
organizations within the community that
30:10
understand the cultural
30:10
barriers of groups.
30:14
So beyond just the Alzheimer's Association, working with specific groups in your
30:16
community and those members of the
30:21
leadership that can explain
30:21
how those communities
30:26
approach different aspects of healthcare
30:26
because everyone is different.
30:30
But I feel that the partnership that we
30:30
have with Alzheimer's Association has
30:34
done a wonderful job of training the
30:34
physicians through continuing education,
30:38
the nursing staff, et cetera. Absolutely.
30:42
And that's one of the reasons why Katie's
30:42
here today because that is really the
30:46
goal of the mission engagement
30:46
division is to really focus
30:51
on not only creating that, but
30:51
really learning from the field.
30:56
We will go out to the health systems,
30:59
we hear from their needs around training
30:59
and then really provide that so we can
31:04
develop that in real time. So Katie,
31:07
any other additional information that
31:07
you'd like to share about how we're
31:12
really supporting the
31:12
training and equipping
31:18
our folks out there that
31:18
are delivering this care?
31:21
Yeah, sure. So everybody
31:21
on this call knows
31:28
that Alzheimer's is a
31:28
complex brain disease.
31:30
So we do believe it's very likely that
31:30
there's going to need to be multiple
31:34
strategies that can reduce risk and
31:34
address the disease in several different
31:39
ways along an individual's life course and
31:44
underrepresented and underserved
31:44
communities we discussed or
31:48
disproportionately impacted,
31:50
and they're less likely to be diagnosed
31:50
and less likely to be recruited to
31:55
participate in research and
31:55
clinical trials like we've shared.
31:58
They're less likely to have access
31:58
to that care and support services.
32:03
And I think Javin mentioned that
32:03
this has got to change and we must do
32:08
better. And so the conversation we believe
32:08
starts with your patients about brain
32:13
health. And just as with
32:13
other chronic conditions,
32:15
the best way to reduce risk
32:15
and detect problems early
32:20
and improve safety and quality of
32:20
care is really to act now. So as
32:25
individuals are managing
32:25
other chronic conditions,
32:28
it is critical to be
32:28
aware of dementia risk.
32:33
And so the Alzheimer's Association, we've been partnering with payers and
32:34
health plans and systems across the
32:38
country really to identify strategies
32:38
and solutions that can provide people
32:43
living with dementia and their caregivers
32:43
just access to these providers and
32:47
systems that prioritize diagnosis and
32:47
care. And for us, that comes in many,
32:52
many forms. It could be
32:52
new digital toolkits,
32:55
it could be continuing education,
32:58
it could be us building
32:58
out recognition programs
33:02
or coaching products and
33:02
building out assessments to help
33:07
people understand where they
33:07
are and where they need to go.
33:10
So really this education for providers,
33:13
we're trying to heighten awareness and
33:13
access to detection and diagnose and of
33:18
course enhanced care coordination,
33:18
the management and access,
33:21
and then ultimately really reduce
33:21
that economic burden of this just
33:25
devastating disease, both for
33:25
people living with the disease,
33:30
the caregivers and healthcare systems,
33:32
and I want to say in all communities
33:32
and really emphasize in all
33:37
communities. Absolutely. And we know, and you
33:39
all have alluded to it already,
33:43
that probably innovation is going
33:43
to be a really critical role to
33:48
help overcome this. So if we think about entrepreneurs
33:49
who may be here today as they think
33:54
about innovation, let's talk about how innovation
33:55
is going to play a role.
34:01
And so I'm wondering, Katie,
34:01
do you have any more comments?
34:04
Would you think about
34:04
technology or innovation,
34:07
how it can be leveraged in specific ways?
34:11
Sure. Currently half of all primary care
34:13
physicians in the United States
34:17
report that they feel unprepared
34:17
to treat patients with dementia.
34:22
And so to respond to this
34:22
challenge in particular,
34:24
the association launched Project Echo,
34:27
which connects leading dementia care
34:27
specialists with care providers in
34:31
communities with high need. And ECHO stands for extension
34:33
in community health outcomes.
34:38
And it's through a knowledge
34:38
sharing that Project Echo is able to
34:43
bring these dementia care
34:43
expertise to local community.
34:46
So it's based on a model created
34:46
at the University of New Mexico
34:51
and Project Echo is really bringing
34:51
mentoring and support from teams of
34:55
specialists to primary care and long-term
34:55
providers in underserved communities.
35:00
So we are trying to increase early
35:00
and accurate diagnosis of dementia
35:06
and that grows affordable high quality
35:06
care and support in these underserved
35:11
areas. We've got some interesting
35:11
statistics too because since
35:15
20 18, 70 2% of long-term care
35:20
respondents strongly agreed or agreed
35:20
that Project Echo improved the quality of
35:25
care. Another stat is 427
35:26
providers have completed
35:30
Project Echo, and I think the one that we're all
35:31
really proud of is almost half a
35:36
million covered lives have been impacted.
35:39
So we know that Project Echo is
35:39
just one example of how innovation
35:43
and technology can be leveraged
35:43
to improve not only clinical
35:48
education but also quality of care
35:48
and then of course health outcomes.
35:54
Thank you. And yes, we have seen a lot of impact
35:55
from our dementia project Echo,
35:59
which is focused on primary
35:59
care. Dr. Bra, what about you?
36:03
When you think about technology and
36:03
innovation and leveraging it to improve
36:08
access to care, what
36:08
comes to mind for you?
36:14
I think there's what already talked about
36:17
around virtual and digital care.
36:20
So that's sort of one
36:20
around just care delivery.
36:25
There's other elements to consider
36:25
around practical and reliable tools to
36:28
identify and monitor the person's
36:28
cognitive, functional, behavioral,
36:32
psychological needs and certainly
36:32
the typically unpaid caregiver
36:37
stress. So there's opportunities to use
36:38
technology in those areas as well.
36:44
How do you continuously evaluate and
36:44
modify a personalized dementia care plan
36:48
That is something can be
36:48
done by the caregiver or with
36:53
other clinical team members.
36:53
Doesn't always need to be
37:01
a clinician that's delivering care that's a nurse practitioner
37:04
or a physician or a pa.
37:07
I mean the other is implementation of
37:07
psychosocial interventions aimed at
37:12
preventing or reducing the diet's
37:12
burden related to cognitive,
37:16
functional and behavioral needs. And then I would say tools to help
37:19
navigate the system and the community of
37:23
resources and needs that individuals
37:23
may have. And then we already see
37:28
technology oriented around
37:28
supporting patients with social
37:32
needs. So there are a number of
37:33
solutions around social
37:38
needs that you can refer,
37:40
navigate people through and then close
37:40
the loop that they've been delivered.
37:45
I would say the other is around some
37:45
of the areas I alluded to earlier
37:49
about the use of AI machine
37:49
learning and sensors
37:55
as well. And then I think voice
37:56
activated tools to generate,
38:00
provide information or guidance or
38:00
even for a caregiver to check in
38:06
on a patient with
38:06
Alzheimer's or other things.
38:08
And I would say that I think we've got
38:08
to do more around managing the agitation
38:13
and the behavioral change that Alzheimer's
38:13
patients experience and how that has
38:17
an impact in their life and
38:17
the life of the caregiver.
38:21
And then the think about the environment
38:21
and how do you create an environment
38:26
that's conducive to minimizing risk and
38:26
harm for those patients. Alzheimer's,
38:30
for example, falling
38:30
may be a consideration.
38:32
So I know that folks in Europe,
38:32
particularly in Denmark,
38:36
taught their patients how to
38:36
fall to minimize injury and risk.
38:41
So these are some of the areas in
38:41
addition to augmenting care models,
38:46
we know work to try to move the needle.
38:50
And I think it can seem overwhelming. So it's just picking what's the one
38:52
thing you're going to try to move in the
38:56
next six months and then six months
38:56
after that to try to have a longitudinal
39:00
plan but in bite-size, practical chunks.
39:05
Well, I appreciate all of that you said,
39:07
because the other thing that you
39:07
really identified when you think about
39:09
innovation is yes, you address
39:09
things like technology and ai,
39:14
but you also thought about
39:14
just thinking outside the box.
39:17
Teaching someone to fall and fall well
39:17
is an innovative way of thinking that
39:22
can prevent harm. And so sometimes
39:22
thinking out of the box. So Ashley,
39:27
what about you? I know you have some experience having
39:28
some new innovation in your practice.
39:32
So tell us where you see innovation
39:32
and technology play a role in improving
39:37
access. I think that it's a great
39:39
frontier and so many
39:43
opportunities are ahead for
39:43
improving access with technology.
39:48
And also this goes a little
39:48
bit to what the pitch
39:53
competition was last year in
39:53
improving testing capabilities within
39:57
primary care or earlier
39:57
detection within primary care.
40:00
And I think they work hand in hand. One of the things I would
40:03
say for organizations,
40:07
startups that are looking to innovate
40:07
in these areas and to be able to move
40:12
into health systems, it's showing the
40:12
ROI being able to demonstrate what it is.
40:16
And to Dr. Bot's point of point,
40:21
be very specific and focus on what
40:21
you can do initially and focus on
40:26
what the codes are that
40:26
are associated with your
40:31
technology or your innovation and how
40:31
that will play out within a health system.
40:35
And understanding general operations
40:35
of a health system and how different
40:39
practices work and every
40:39
organization is different,
40:42
but to get in the door is to have that
40:42
basic understanding and to be able to
40:46
clearly demonstrate the ROI and what
40:46
you value your technology or your
40:51
innovation brings not only to the patient,
40:54
but to the providers and the organization
40:54
overall I think is imperative to be
40:58
able to move forward in this area. Yeah, absolutely.
41:01
And that's part of why we created the
41:01
Alzheimer's Association Innovation
41:04
Roundtable and have our pitch
41:04
competition because we know that
41:09
more innovation is needed and it's
41:09
an opportunity to really share that.
41:12
And as Ashley said, based
41:12
on the winner last year,
41:16
she liked what she saw and she began
41:16
to put more innovation in her system.
41:21
So we have a lot of questions, so
41:21
hopefully we can get through some of them.
41:26
So first question is what
41:26
are the top low hanging fruit
41:30
opportunities that you
41:30
see that should be in the
41:34
ecosystem of startups but isn't?
41:38
So where are those gaps in that ecosystem?
41:43
And then why isn't a solution?
41:48
Let's see, a little bit of a typo,
41:48
but taking care of loved ones.
41:52
I think that's the question. So where are the low hanging fruit
41:54
opportunities for the startups
41:59
and potentially even solutions
41:59
for loved ones or caregivers?
42:04
Dr. bha, I might call on you for that one because
42:05
you've talked a little bit about that.
42:14
I think I would just reference back to
42:17
some of our earlier points on
42:22
thinking about where there's opportunity
42:22
to help coordinate services more
42:26
effectively, helping drive
42:26
navigation and care planning
42:32
tools that can help educate
42:32
more effectively caregivers
42:37
and patients earlier on in the process
42:37
about what to expect and how to
42:42
plan for it. I think this is
42:42
something that if you plan for,
42:47
it's not going to be perfect
42:47
and can still have challenges,
42:51
but can mitigate a lot of
42:51
what may happen that may
42:56
lead to suffering or poor
42:56
care or hospital visits or
43:01
acceleration of the condition. So whether it's medication support from
43:09
orienting people to familiar environments
43:09
to knowing they even think about,
43:15
we have medically
43:15
tailored meals for people,
43:19
what about medically tailored
43:19
playlists for those with dementia?
43:24
Helping people think
43:24
about what helps them stay
43:29
grounded and things that are
43:29
familiar and manage for that
43:34
agitation. So I think there's a lot
43:36
of places to start between
43:41
supporting people through
43:41
treatment, catching them earlier,
43:44
and supporting them to monitoring their
43:44
journey to supporting care coordination
43:49
and caregiver services and helping support managing
43:54
and updating a care plan.
43:58
Absolutely. Thank you. So we had one
43:58
question here about the US pointer study,
44:02
so we can send out, so I don't
44:02
know, Ashley, if you have a second,
44:05
you can drop a link in. If not,
44:05
we can certainly send out more of,
44:09
this study is actually wrapping up.
44:13
It's looking at lifestyle,
44:13
so that's coming soon.
44:16
I believe there's information even on our website, az.org around the pointer study
44:18
that you can learn more about that.
44:23
I'm kind of just going through
44:23
here. Yeah, go ahead Katie.
44:28
I wanted to say one of the first
44:28
questions I did was that I might've
44:32
accidentally deleted, but I saw
44:32
you, so I feel compelled to answer.
44:37
But it was how can the Alzheimer's
44:37
Association help startups?
44:41
And I wanted to share that
44:41
we do offer collaboration in
44:46
pre-competitive environments through
44:46
a few different round tables.
44:49
Most notably is the innovation round
44:49
table that Ashley is a chair of.
44:54
And again, this is a round table that
44:54
brings together innovators, champions,
44:59
experts, thought leaders, really
44:59
across that healthcare sector.
45:03
And they're looking at ways to
45:03
ultimately reduce risk and improve early
45:07
detection, increase access to evidence-based
45:08
person-centered care for those facing
45:12
dementia and Alzheimer's. And then we also have something called
45:14
the Alzheimer's Association Business
45:18
Consortium. And the goal with this group
45:19
is really to advance the
45:23
disease and dementia
45:23
research through innovation,
45:27
and that is through small and
45:27
medium-sized biotech diagnostics,
45:32
medical device and contract
45:32
research organizations.
45:35
So the members of the
45:35
small business consortium,
45:39
they work in areas of common interest,
45:39
again, pre-com competitively,
45:44
so that they can advance the field of
45:44
dementia research and the goals of their
45:49
organization. So the team really provides leadership and
45:52
direction to the group's area of focus,
45:57
which includes collaborations
45:57
and recognition,
46:00
visibility and knowledge and information sharing. And I know we're going to talk a little
46:02
bit later about the pitch competition,
46:05
but these round tables,
46:05
you can find it@az.org,
46:08
are other new ways we are able
46:08
to support those startups.
46:12
Thank you, Katie. Actually, I did
46:12
see that, and you're right then.
46:14
I didn't see it. It had disappeared. So I'm glad that you remembered
46:17
one question in here.
46:20
Is there a way that you can provide
46:20
support for families with members of
46:25
dementia and Alzheimer's?
46:25
Absolutely. So if you go to az.org,
46:29
there is a robust list
46:29
of resources through ALS
46:34
connected and Alz Navigator
46:34
also in your community
46:38
is nearby a local chapter
46:38
that have local in-person
46:43
support groups and education and ongoing.
46:46
Ashley alluded how closely she's been
46:46
working with our Houston chapter.
46:51
So we do have chapters all throughout
46:51
the nation, but whether it's online,
46:55
you can also call her 800 number
46:55
twenty four seven helpline with
47:01
dementia trained care and support persons
47:01
that really support those living with
47:06
the disease and their caregivers.
47:06
So we certainly can help with that,
47:09
but az.org is a great place to start
47:09
with that. Let me read through,
47:13
because we're going to kick it to
47:13
Casey in just a minute this here.
47:18
How would you encourage entrepreneurs to
47:18
make solutions that plug into existing
47:23
ecosystems of care and tech
47:23
tools instead of making countless
47:28
standalone solutions?
47:31
Anyone have a thought
47:31
or comment about that?
47:35
That's a really, I can start one.
47:35
I would say co-creation, co-design,
47:39
who's thinking about with whoever
47:39
the solution is oriented towards,
47:44
and ideally both care team
47:44
member as well as patient and
47:49
family caregiver, caregiver impacted,
47:52
that's one I would say see where
47:52
there's gaps in a geography or in a
47:57
system of care and see
47:57
where you can plug in to
48:02
help address a gap there that
48:02
then could be elsewhere and
48:07
grow. I would see where there's also,
48:13
where we don't necessarily have research
48:13
around aspects of the care model,
48:18
and I do think some of the analytics,
48:18
artificial intelligence, machine learning,
48:22
sensor voice, there's a
48:22
number of open spaces there,
48:27
and I'm not a consumer
48:27
electronics show this year,
48:30
but it'll be interesting to see
48:30
what they have brewing in terms of
48:35
emerging technology that is
48:40
enabling better, safer,
48:43
high quality care for
48:43
patients with dementia.
48:48
And then there is still
48:48
biotech, biopharma,
48:52
MedTech those communities as well.
48:57
Well, this has been an amazing
48:57
discussion and I am so grateful for the
49:02
panelists today. So now I would like to
49:04
introduce to you Casey Sheridan.
49:08
She is the partnership manager at
49:08
Matter to provide a brief overview
49:12
of the second annual
49:12
Alzheimer's Association pitch
49:17
are interested in applying.
49:17
So Casey, I'll hand it to you.
49:22
Awesome, thank you Laura, and thank
49:22
you so much, Dr. Bhatt, Ashley,
49:26
Katie, so much for your
49:26
time and expertise today.
49:29
That was a fantastic
49:29
discussion. Like Laura said,
49:34
matter is thrilled to be powering
49:34
and partnering with the Alzheimer's
49:38
Association on our second
49:38
annual pitch competition,
49:41
and I'm going to spend just a couple of
49:41
minutes here providing a few details for
49:46
those that are listening
49:46
in that are interested in
49:52
So to start off, as we mentioned earlier,
49:55
the focus for this
49:55
year's pitch competition,
49:58
our solutions that are working to
49:58
increase access to quality person-centered
50:02
care for underserved people living
50:02
with Alzheimer's disease or related
50:06
dementias. So if you are a solution
50:06
that's working towards this goal,
50:11
then you absolutely qualify and we
50:11
encourage you to apply to this program.
50:17
So this is a high level snapshot of the
50:17
timeline that we are working towards.
50:22
So applications are currently
50:22
open. My colleague Kay,
50:27
who's on the Zoom here is about to
50:27
drop the application link in the chat
50:32
so you can check out
50:32
more information there.
50:35
Applications will close a
50:35
week from Friday, so Friday,
50:38
January 19th at midnight central time.
50:42
From there we'll have a review and
50:42
selection committee that'll be carefully
50:46
reviewing all the applications and we'll
50:46
announce the top five finalists who
50:50
will be moving forward in the
50:50
program by February 7th of this year.
50:56
From there, we'll have those five
50:56
finalists participate in a
51:01
weeks long from February
51:01
12th to March 18th,
51:06
receiving expert mentorship and
51:06
exclusive resources to build their
51:10
solutions and to refine
51:10
their value propositions.
51:16
Lastly, the program will culminate in a pitch
51:16
competition that'll be in person
51:22
at matters offices in downtown
51:22
Chicago on Tuesday, March 19th,
51:27
where the five finalists will have an
51:27
opportunity to pitch their solution to
51:31
a panel of industry experts
51:31
as well as a live audience,
51:35
both in person and virtually of
51:35
key stakeholders in the room.
51:40
The first place startup will
51:40
be awarded a cash prize,
51:44
$15,000 and a six month
51:44
comp matter membership.
51:48
And the second and third place startups
51:48
will receive a cash prize of $5,000
51:53
each four submission criteria.
51:59
These are the four kind of main
51:59
boxes to check to make sure
52:04
that you are all good to apply to
52:07
the program. So again,
52:10
we're seeking entrepreneurs who are
52:10
developing solutions that are working to
52:14
increase access to quality person-centered
52:14
care for underserved people living
52:17
with Alzheimer's disease
52:17
or related dementias.
52:21
This is a global call for solutions, so it does not matter
52:23
where you are in the world.
52:26
We're accepting solutions that are
52:26
both based in the US and across
52:31
the rest of the world. Our programs also open to individuals
52:35
and teams from across the entire
52:40
healthcare innovation ecosystem. So
52:40
whether you're a university researcher,
52:44
if you're a student, if
52:44
you're an entrepreneur,
52:47
if you're already an existing
52:47
startup of any stage,
52:50
you absolutely qualify to apply to
52:50
this program ranging from early stage
52:55
concepts all the way up through marketed
52:55
solutions and full-blown businesses.
53:02
The selection criteria that the
53:02
Review and Selection committee will be
53:06
primarily focused on when reviewing
53:06
your application is detailed here on the
53:11
screen. So first and foremost,
53:13
the ability to clearly articulate
53:13
the challenge statement
53:18
addressed in the program description.
53:20
So if you can convey how
53:20
your solution is working,
53:25
the goal that we outline
53:25
in the challenge statement,
53:28
clearly in your application,
53:28
that will give you huge points.
53:32
We'll also be looking at the quality
53:32
feasibility and scale of your proposed
53:36
solution or technology. We'll be looking at the differentiation
53:38
of your solution within the competitive
53:42
landscape. We'll be assessing
53:42
the capability of you and your
53:46
team to develop and execute the
53:46
solution that you propose and
53:52
as well as the ability of your solution
53:52
to actually increase access to quality
53:56
person-centered care for underserved
53:56
folks living with Alzheimer's disease
54:03
benefit benefits of participation. So the five startups that are
54:05
accepted as finalists into
54:10
the programs will be engaging
54:10
with other cutting edge startups.
54:14
They'll be networking with peers working
54:14
within the same space and leading
54:18
influencers in the space. They'll receive expert mentorship from
54:20
industry leaders and subject matter
54:24
experts to validate their solutions
54:24
and refine their value propositions.
54:28
Accepted startups will gain exposure
54:28
to both the Alzheimer's Association and
54:32
Matter communities. They'll have the opportunity to pitch
54:34
their solution to a live audience
54:39
with potential investors, partners,
54:39
clients, and mentors in the audience.
54:45
That'll be, again, in person in
54:45
Chicago on Tuesday, March 19th,
54:49
as well as the opportunity to win that
54:49
cash prize that I detailed earlier.
54:57
So like I mentioned, the deadline
54:57
to submit is next Friday,
55:00
January 19th at midnight central time.
55:03
If you have any questions between now
55:03
and then about your application or if you
55:07
qualify to apply, please feel free
55:07
to email me. Again, my name is Casey,
55:12
C-I-S-E-Y at Matter Health,
55:15
and I'll be happy to meet with you and
55:15
answer any questions that you have.
55:20
Please visit Matter Health
55:20
slash Challenges to find
55:24
and more background information. And we're excited to read all of your
55:27
applications and get everyone back
55:31
together again at the final
55:31
Pitch Competition on March 19th.
55:36
So that is all we have for today. I want to just say thank you again to
55:38
the Alzheimer's Association for your
55:42
partnership on this
55:42
initiative and many others.
55:45
We love working with you and thank
55:45
you so much, Dr. Bhat, Ashley, Katie,
55:50
and Laura for your time for
55:50
today's program. And lastly,
55:53
thanks to you all who have
55:53
joined our call today.
55:56
We hope that you learned something and
55:56
please feel free to reach out with any
56:00
questions. Hope you have
56:00
a great rest of your day.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More